CN Patent

CN111278433A — 尼拉帕尼制剂

Assigned to Texano Ltd · Expires 2020-06-12 · 6y expired

What this patent protects

本发明涉及适于口服给药的包含化合物尼拉帕尼作为活性药物成分的药物片剂组合物及其制备方法。本文还描述了通过所公开的方法形成的含有尼拉帕尼的片剂组合物，以及这种片剂组合物在治疗各种疾病和病症中的治疗用途。

USPTO Abstract

本发明涉及适于口服给药的包含化合物尼拉帕尼作为活性药物成分的药物片剂组合物及其制备方法。本文还描述了通过所公开的方法形成的含有尼拉帕尼的片剂组合物，以及这种片剂组合物在治疗各种疾病和病症中的治疗用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN111278433A
Jurisdiction: CN
Classification: —
Expires: 2020-06-12
Drug substance claim: No
Drug product claim: No
Assignee: Texano Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.